Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy InspireMD stock | $0.35

Own InspireMD stock in just a few minutes.

Fact checked

InspireMD, Inc is a medical devices business based in the US. InspireMD shares (NSPR) are listed on the NYSE MKT and all prices are listed in US Dollars. InspireMD employs 48 staff and has a trailing 12-month revenue of around USD$3.3 million.

How to buy shares in InspireMD

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for InspireMD. Find the stock by name or ticker symbol: NSPR. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until InspireMD reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$0.35, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of InspireMD, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of InspireMD. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

InspireMD share price

Use our graph to track the performance of NSPR stocks over time.

InspireMD shares at a glance

Information last updated 2020-11-30.
Latest market closeUSD$0.35
52-week rangeUSD$0.28 - USD$1.55
50-day moving average USD$0.3544
200-day moving average USD$0.4521
Wall St. target priceUSD$0.85
PE ratio 0.5892
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-9.906

Buy InspireMD shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy InspireMD stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

InspireMD price performance over time

Historical closes compared with the close of $0.35 from 2020-12-09

1 week (2021-01-07) -28.57%
1 month (2020-12-17) 9.37%
3 months (2020-10-15) 9.37%
6 months (2020-07-15) -20.45%
1 year (2020-01-15) -69.83%
2 years (2019-01-15) 110.84%
3 years (2018-01-13) N/A
5 years (2016-01-15) 0.7

Is InspireMD under- or over-valued?

Valuing InspireMD stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of InspireMD's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

InspireMD's P/E ratio

InspireMD's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, InspireMD shares trade at around 1x recent earnings.

InspireMD financials

Revenue TTM USD$3.3 million
Gross profit TTM USD$756,000
Return on assets TTM -40.25%
Return on equity TTM -96.45%
Profit margin -276.89%
Book value $0.313
Market capitalisation USD$13 million

TTM: trailing 12 months

Shorting InspireMD shares

There are currently 722,671 InspireMD shares held short by investors – that's known as InspireMD's "short interest". This figure is 4.9% up from 689,121 last month.

There are a few different ways that this level of interest in shorting InspireMD shares can be evaluated.

InspireMD's "short interest ratio" (SIR)

InspireMD's "short interest ratio" (SIR) is the quantity of InspireMD shares currently shorted divided by the average quantity of InspireMD shares traded daily (recently around 1.1 million). InspireMD's SIR currently stands at 0.63. In other words for every 100,000 InspireMD shares traded daily on the market, roughly 630 shares are currently held short.

However InspireMD's short interest can also be evaluated against the total number of InspireMD shares, or, against the total number of tradable InspireMD shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case InspireMD's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 InspireMD shares in existence, roughly 20 shares are currently held short) or 0.0196% of the tradable shares (for every 100,000 tradable InspireMD shares, roughly 20 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against InspireMD.

Find out more about how you can short InspireMD stock.

InspireMD share dividends

We're not expecting InspireMD to pay a dividend over the next 12 months.

Have InspireMD's shares ever split?

InspireMD's shares were split on a 1:50 basis on 1 April 2019. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your InspireMD shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for InspireMD shares which in turn could have impacted InspireMD's share price.

InspireMD share price volatility

Over the last 12 months, InspireMD's shares have ranged in value from as little as $0.28 up to $1.55. A popular way to gauge a stock's volatility is its "beta".

NSPR.US volatility(beta: 2.46)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while InspireMD's is 2.456. This would suggest that InspireMD's shares are significantly more volatile than the average for this exchange and represent a higher risk.

InspireMD overview

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. is headquartered in Tel Aviv, Israel.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site